Date Range
toReport Types
Condition
See all (83)
Region of the Body
See all (22)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Compliance to oral bisphosphonate therapy similar regardless of follow-up type
Osteoporos Int. 2014 Apr;25(4):1345-55. doi: 10.1007/s00198-013-2610-4. Epub 2014 Jan 21.
Denosumab increases BMD and reduces bone turnover vs monthly oral bisphosphonate
Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28.
Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
Timing of bisphosphonate administration does not affect fracture healing or complications
J Bone Joint Surg Br. 2012 Jul;94(7):956-60
Bone mineral density loss following total joint arthroplasty mitigated by bisphosphonate therapy
Osteoporos Int. 2018 Jul;29(7):1525-1537. doi: 10.1007/s00198-018-4488-7
Oral ibandronic acid inferior to IV zoledronic acid for metastatic breast cancer to bone
Lancet Oncol. 2014 Jan;15(1):114-22. doi: 10.1016/S1470-2045(13)70539-4.
Early bisphosphonate use after surgery does not appear to delay fracture healing
Osteoporos Int. 2015 Feb;26(2):431-41.
Bisphosphonates effective in osteoporotic males in terms of fracture, BMD, and biomarkers
Osteoporos Int. 2015 Sep;26(9):2355-63.
Early Bisphosphonate Therapy on Time to Fracture Healing in Proximal Femur Fixation
ANZ J Surg. 2022 01-Jun;():. 10.1111/ans.17792
Topical drug-free therapy more effective than oral NSAID ketoprofen for muscle soreness
J Sports Sci. 2016 Jan;34(1):88-95.
Improved bone mineral density up to 12 months with a 6-month oral alendronate intervention
J Bone Joint Surg Am. 2006 Feb;88(2):267-72
Oral alendronate cannot yet be recommended for children with OI
J Clin Endocrinol Metab. 2011 Feb;96(2):355-64
Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy
J Orthop Surg Res. 2018 Sep 4;13(1):225. doi: 10.1186/s13018-018-0918-7
Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients
Osteoporos Int. 2016 Jan;27(1):295-9
Three-month course of oral antibiotics reduces PJI rate after two-stage revision
Clin Orthop Relat Res. 2017 Jan;475(1):56-61